OSTEOARTHRITIS
Efficacy evaluation of highly purified intra-articular hyaluronic acid vs hylan G-F20
This report has been verified
by one or more authors of the
original publication.
. 2011 ;():.
381 patients with knee osteoarthritis (OA) were randomized to receive intra-articular injections with either Synovail (highly purified intra-articular hyaluronic acid) or Synvisc (hylan G-F20) once a week for three weeks. This double blinded randomized trial examined the efficacy and non-inferiority of Synovial treatment in patients with OA of the knee. The results from this study indicate that both treatments provide significant reductions in the WOMAC Index pain sub-scores at 6 months. Comparisons of mean WOMAC Index pain sub-score decreases from baseline between groups indicate that the treatments are equivalent.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
